3 completed, 3 terminated, 1 withdrawn. 5 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Terminated 3, Completed 2 |
| Phase 2 | 1 | Withdrawn 1 |
Follow this drug Literature Review of Tomography, Emission-Computed trials Research Report on Tomography, Emission-Computed
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation 18F-FPPRGD2, Positron emission tomography, Computed tomography - Aortic Aneurysm, Abdominal, Carotid Atherosclerosis | Phase 2 | Withdrawn | Stanford University | 2019-10-01 | 2021-05-21 | |
| 64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer copper Cu 64-DOTA-trastuzumab, positron emission tomography, laboratory biomarker analysis - Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach | Not applicable | Completed | City of Hope Medical Center | 8 | 2014-11-19 | 2025-02-28 |
| FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents fluorine F 18 fluorothymidine, positron emission tomography, magnetic resonance imaging - Unspecified Adult Solid Tumor, Protocol Specific | Completed | Case Comprehensive Cancer Center | 10 | 2013-10-22 | 2020-09-18 | |
| PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases positron emission tomography, computed tomography, magnetic resonance imaging - Cardiac Disease, Dementia | Not applicable | Completed | Case Comprehensive Cancer Center | 72 | 2013-03-07 | 2019-10-29 |
| FDG-PET in Advanced Melanoma [18F]fluorodeoxyglucose, Molecular assays on biopsied tissue, positron emission tomography - Recurrent Melanoma, Stage IIIA Melanoma | Not applicable | Terminated | Vanderbilt-Ingram Cancer Center | 3 | 2012-05-01 | 2017-04-13 |
| Positron Emission Tomography/Magnetic Resonance Imaging in Patients magnetic resonance imaging with positron emission tomography scanning - Colon Cancer, Head and Neck Cancer | Not applicable | Terminated | Case Comprehensive Cancer Center | 98 | 2012-02-01 | 2020-02-24 |
| FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer fludeoxyglucose F 18, positron emission tomography, dynamic contrast-enhanced magnetic resonance imaging - Male Breast Cancer, Stage II Breast Cancer | Not applicable | Terminated | University of Washington | 35 | 2011-11-01 | 2023-11-18 |
Melanoma (2) · Aortic Aneurysm, Abdominal (1) · Atherosclerosis (1) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Carotid Artery Diseases (1) · Carotid Stenosis (1) · Colonic Neoplasms (1) · Dementia (1) · Fever of Unknown Origin (1) · Head and Neck Neoplasms (1) · Heart Diseases (1) · Inflammation (1) · Lung Neoplasms (1) · Lymphoma (1)
Case Comprehensive Cancer Center (3) · City of Hope Medical Center (1) · Stanford University (1) · University of Washington (1) · Vanderbilt-Ingram Cancer Center (1)
United States (7)
Jennifer Specht (1) · Michael V. McConnell, MD, MSEE (1) · Norbert Avril (1) · Pablo Ros, MD, MPH, PhD (1) · Peter Faulhaber (1) · Tom Yankeelov, PhD (1) · Yanghee Woo, MD (1)
P30CA015704 (1), P30CA043703 (1), P30CA068485 (1), P50CA138293 (1)